JUN 26, 2022 1:30 PM PDT

Acupuncture Alleviates Chronic Tension Headaches in Randomized Controlled Trial

WRITTEN BY: Annie Lennon

Results from a randomized controlled trial suggest that acupuncture may relieve symptoms of chronic tension-type headaches. The corresponding study was published in Neurology

Tension-type headaches occur when the neck and scalp muscles become tense or contract. They may occur in response to stress, depression, head injury, or anxiety, and are considered chronic when they occur for more than 15 days per month. 

“Tension-type headaches are one of the most common types of headaches, and people who have a lot of these headaches may be looking for alternatives to medication,” said study author Ying Li, MD, Ph.D., of Chengdu University of Traditional Chinese Medicine in Chengdu, China.

For the study, the researchers recruited 218 people who had chronic tension-type headaches for an average of 11 years, with headaches occurring an average of 22 days per month. They were randomly assigned groups and received either ‘true acupuncture’ or 'superficial acupuncture' as a control. 

True acupuncture was defined as achieving a ‘deqi sensation’- that is, placing and moving a needle in the body until it induces a tingling, numbness, or heaviness. Meanwhile, superficial treatments were defined as more shallow placements of needles that did not induce these sensations. 

Both groups underwent treatment two to three times per week for a total of two months, and were followed for six months after treatment. 

In the end, the researchers noted that 68% of people who received true acupuncture reported at least a 50% reduction in their number of monthly headaches. The same was true for 50% of people who received superficial acupuncture. 

The researchers additionally found that the number of monthly headache days gradually decreased after treatment in both groups. 

“While this study showed that acupuncture can reduce headaches, more research is needed to determine the longer-term effectiveness of acupuncture and how it compares to other treatment options,” said Li. “In comparing treatment options, cost-effectiveness is another important factor to evaluate.”


Sources: Neuroscience News, Neurology

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
MAY 31, 2022
Drug Discovery & Development
Computer Models Help Find Antibiotics to Fight Drug-Resistant Pathogens
MAY 31, 2022
Computer Models Help Find Antibiotics to Fight Drug-Resistant Pathogens
Antibiotics were a revolutionary tool in the fight against bacterial infections. In recent years, however, the emergence ...
JUL 01, 2022
Drug Discovery & Development
Paper-thin Device Treats Pain and then Dissolves in Body
JUL 01, 2022
Paper-thin Device Treats Pain and then Dissolves in Body
Researchers have developed a biocompatible, implantable device that relieves pain and harmlessly dissolves when no longe ...
JUL 04, 2022
Cannabis Sciences
Study calls for Improved Cannabis Product Labeling Practices
JUL 04, 2022
Study calls for Improved Cannabis Product Labeling Practices
Large scale study of cannabis product labeling highlights a critical need for more informative and accurate product desc ...
JUL 05, 2022
Immunology
A New Type of Universal Flu Vaccine
JUL 05, 2022
A New Type of Universal Flu Vaccine
Researchers have created a new 'universal' flu vaccine, which is directed against type A influenza viruses. It w ...
JUL 06, 2022
Drug Discovery & Development
The new amphibious origami millirobot can roll, flip, and spin for targeted drug delivery
JUL 06, 2022
The new amphibious origami millirobot can roll, flip, and spin for targeted drug delivery
Drug delivery researchers are constantly exploring ways that can help improve targeted drug delivery. When a drug is ing ...
JUL 08, 2022
Cannabis Sciences
$2 Million in NIH Awards go to Study Adolescent Cannabis Use
JUL 08, 2022
$2 Million in NIH Awards go to Study Adolescent Cannabis Use
The NIH's National Institute on Drug Abuse awarded more than $2 million to Indiana University’s Gill Center fo ...
Loading Comments...